Kiora Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing and commercializing therapies for the treatment of ophthalmic diseases. Its pipeline consists of three product candidates, including KIO-101,... Read more
MarketWatch
Yahoo
SeekingAlpha
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.